Status:
UNKNOWN
Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
Lead Sponsor:
Sechenov University
Collaborating Sponsors:
Pirogov Russian National Research Medical University
Conditions:
Pemphigus
Bullous Pemphigoid
Eligibility:
All Genders
Brief Summary
Pemphigus is a rare autoimmune life-threatening blistering condition affecting skin and mucous membranes. Pemphigus belongs to a family of polygenic disorders. Several different genes encoding molecul...
Eligibility Criteria
Inclusion
- Signed informed consent
- Age of patients \>18 years
- Confirmed diagnosis
Exclusion
- No as pemphigus is a life-threatening condition
Key Trial Info
Start Date :
May 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 17 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05284929
Start Date
May 17 2017
End Date
March 17 2023
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sechenov University
Moscow, Russia, 119991